ARTICLES
Hazards of small clinical trials
S Piantadosi
JCO Jan 1 1990: 1–3. [PDF]
A third option in the management of patients with clinical stage I nonseminomatous germ cell tumor?
VH Gressler, LA Levine, and NJ Vogelzang
JCO Jan 1 1990: 4–8. [PDF]
	Hydrazine sulfate influence on nutritional status and survival in non- small-cell lung cancer
	RT Chlebowski, L Bulcavage, M Grosvenor, E Oktay, JB Block, JS Chlebowski, I Ali, and R Elashoff
	JCO Jan 1 1990: 9–15. [Abstract] [PDF]
	Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial
	J Pont, W Holtl, D Kosak, E Machacek, H Kienzer, H Julcher, and N Honetz
	JCO Jan 1 1990: 16–20. [Abstract] [PDF]
	Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer
	M Boyer, D Raghavan, PJ Harris, J Lietch, A Bleasel, JC Walsh, S Anderson, and CS Tsang
	JCO Jan 1 1990: 21–26. [Abstract] [PDF]
	Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group
	JA Levi, D Thomson, V Harvey, G Gill, D Raghavan, M Tattersall, R Snyder, I Burns, T Sandeman, and M Byrne
	JCO Jan 1 1990: 27–32. [Abstract] [PDF]
	Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group
	JR Jett, L Everson, TM Therneau, JE Krook, RJ Dalton, RF Marschke, Jr, MH Veeder, SF Brunk, JA Mailliard, and DI Twito
	JCO Jan 1 1990: 33–38. [Abstract] [PDF]
	Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study
	GE Goodman, JJ Crowley, JC Blasko, RB Livingston, TM Beck, MD Demattia, and RM Bukowski
	JCO Jan 1 1990: 39–47. [Abstract] [PDF]
	Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung cancer: further follow-up of 6- to 13-year survivors
	BE Johnson, N Patronas, W Hayes, J Grayson, B Becker, D Gnepp, J Rowland, A Anderson, E Glatstein, and DC Ihde
	JCO Jan 1 1990: 48–56. [Abstract] [PDF]
	The prognostic value of testicular biopsy in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group
	DR Miller, SL Leikin, VC Albo, NF Palmer, HN Sather, and GD Hammond
	JCO Jan 1 1990: 57–66. [Abstract] [PDF]
	Adrenocortical carcinoma in children: a study of 40 cases
	RC Ribeiro, RS Sandrini Neto, MJ Schell, L Lacerda, GA Sambaio, and I Cat
	JCO Jan 1 1990: 67–74. [Abstract] [PDF]
	Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia
	DK Kalwinsky, SC Raimondi, MJ Schell, J Mirro, Jr, VM Santana, F Behm, GV Dahl, and D Williams
	JCO Jan 1 1990: 75–83. [Abstract] [PDF]
	The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen
	MA Shipp, BY Yeap, DP Harrington, MM Klatt, GS Pinkus, MS Jochelson, DS Rosenthal, AT Skarin, and GP Canellos
	JCO Jan 1 1990: 84–93. [Abstract] [PDF]
	Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas
	AM Schneider, DJ Straus, AE Schluger, DA Lowenthal, B Koziner, BJ Lee, G Wong, and BD Clarkson
	JCO Jan 1 1990: 94–102. [Abstract] [PDF]
	Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer
	S Paik, R Hazan, ER Fisher, RE Sass, B Fisher, C Redmond, J Schlessinger, ME Lippman, and CR King
	JCO Jan 1 1990: 103–112. [Abstract] [PDF]
	The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast
	R Holland, JL Connolly, R Gelman, M Mravunac, JH Hendriks, AL Verbeek, SJ Schnitt, B Silver, J Boyages, and JR Harris
	JCO Jan 1 1990: 113–118. [Abstract] [PDF]
	Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus
	AA Forastiere, MB Orringer, C Perez-Tamayo, SG Urba, S Husted, BJ Takasugi, and M Zahurak
	JCO Jan 1 1990: 119–127. [Abstract] [PDF]
	Expression of the multidrug resistance, MDR1, gene in neuroblastomas
	LJ Goldstein, AT Fojo, K Ueda, W Crist, A Green, G Brodeur, I Pastan, and MM Gottesman
	JCO Jan 1 1990: 128–136. [Abstract] [PDF]
	A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer
	SB Howell, S Kirmani, WE Lucas, S Zimm, R Goel, S Kim, MC Horton, L McVey, J Morris, and RJ Weiss
	JCO Jan 1 1990: 137–145. [Abstract] [PDF]
	Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer
	M Markman, M George, T Hakes, B Reichman, W Hoskins, S Rubin, W Jones, L Almadrones, and JL Lewis, Jr
	JCO Jan 1 1990: 146–150. [Abstract] [PDF]
	Phase II trial of carboplatin in the management of malignant mesothelioma
	D Raghavan, P Gianoutsos, J Bishop, J Lee, I Young, P Corte, P Bye, and B McCaughan
	JCO Jan 1 1990: 151–154. [Abstract] [PDF]
	Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sezary syndrome
	EC Kohn, RG Steis, EA Sausville, SR Veach, JL Stocker, R Phelps, S Franco, DL Longo, PA Bunn, and DC Ihde
	JCO Jan 1 1990: 155–160. [Abstract] [PDF]
	A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy
	SN Bock, RE Lee, B Fisher, JT Rubin, DJ Schwartzentruber, JP Wei, DP Callender, JC Yang, MT Lotze, and PA Pizzo
	JCO Jan 1 1990: 161–169. [Abstract] [PDF]
	High-dose ifosfamide with mesna uroprotection: a phase I study
	AD Elias, JP Eder, T Shea, CB Begg, E Frei, 3d, and KH Antman
	JCO Jan 1 1990: 170–178. [Abstract] [PDF]
Staging of neuroblastoma
N Nagahara, H Ohkawa, H Suzuki, Y Tsuchida, and T Nakajou
JCO Jan 1 1990: 179a. [PDF]
Treatment-related ototoxicity
DA Walker and KD Waters
JCO Jan 1 1990: 179b–180. [PDF]
Reporting of clinical trials
D Pinkel and E Gehan
JCO Jan 1 1990: 180–182. [PDF]
Warfarin anticoagulation for small-cell lung cancer: evidence against a cytotoxic or anticoagulant mechanism
JM Silberberg and S Zucker
JCO Jan 1 1990: 182–184. [PDF]
Clarification
AG Meek
JCO Jan 1 1990: 184. [PDF]

SPECIAL DEPARTMENTS
ERRATUM
	The Modulation of Fluorouracil With Leucovorin in Metastatic Colorectal Carcinoma: A Prospective Randomized Phase III Trial
	Nicholas Petrelli, Harold O. Douglass, Jr, Lemuel Herrera, David Russell, Donald M. Stablein, Howard W. Bruckner, Robert J. Mayer, Roger Schinella, Michael D. Green, Franco M. Muggia, Alec Megibow, Edward S. Greenwald, Ronald M. Bukowski, Jules Harris, Bernard Levin, Ellen Gaynor, Antoine Loutfi, Martin H. Kalser, Jamie S. Barkin, Pasquale Benedetto, Paul V. Woolley, Russell Nauta, Donald W. Weaver, and Lawrence P. Leichman for the Gastrointestinal Tumor Study Group
	JCO Jan 1 1990: 185. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.